Lisinopril Tablets — Class II drug recall D-0061-2025
Terminated recall by Evaric Pharmaceuticals Inc., reported 2024-11-27, distributed nationwide. Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
| Recall number | D-0061-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Evaric Pharmaceuticals Inc., Hauppauge, NY, United States |
| Recall initiated | 2024-11-15 |
| Classified | 2024-11-20 |
| Reported by FDA | 2024-11-27 |
| Terminated | 2026-04-23 |
| Distributed | Nationwide (US) |
| Reason classes | foreign material |
| NDC | 68645-0608, 68645-0608-90, 68645-0609, 68645-0609-90, 68645-0610, 68645-0610-90, 68645-0611, 68645-0611-90, 68645-0612, 68645-0612-90, 68645-0613, 68645-0613-90 |
| Lot numbers | 241103 |
| Expiration dates | 2026-05-31 |
Product
Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC# 68645-610-90.
Reason for recall
Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0061-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.